Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 8,978 ETON shares, $562.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Sale | 8,978 | $562.5K |
| Aug 4, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 128,985 | n/a |
| Jul 14, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 27,500 | n/a |
| May 29, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Sale | 119,852 | $3.82M |
| Jan 14, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Tax Withholding | 5,015 | $77.2K |
| Dec 12, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Tax Withholding | 6,732 | $113.3K |
| Jun 5, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Sale | 60,945 | $1.06M |
| Jan 6, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 107,469 | n/a |
| Feb 15, 2024 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 438,633 | n/a |
| Mar 3, 2023 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 350,381 | n/a |